U.S. Children Make Over 6 Million Office Visits/Year for ADHD

Share this content:
U.S. Children Make Over 6 Million Office Visits/Year for ADHD
U.S. Children Make Over 6 Million Office Visits/Year for ADHD

FRIDAY, Jan. 27, 2017 (HealthDay News) -- An average 6.1 million physician visits in 2012 to 2013 were made by children aged 4 to 17 with a primary diagnosis of attention-deficit/hyperactivity disorder (ADHD), according to a January data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics (NCHS).

The number represents 6 percent of all children's visits to the doctor in 2013, senior author Jill Ashman, Ph.D., a statistician with the NCHS, told HealthDay. The percentage has increased from a decade earlier, when 4 percent of physician visits were related to ADHD, she said.

The ADHD visit rate was more than twice as high for boys as for girls. Boys visited the doctor at a rate of 147 per 1,000, compared with 62 per 1,000 for girls. Forty-eight percent of visits for ADHD by children were with pediatricians. Thirty-six percent were with psychiatrists and 12 percent were with family doctors. The authors note that 29 percent of ADHD visits also included diagnosis of an additional mental health disorder. These included episodic mood disorder and anxiety.

Eight out of 10 doctor visits for ADHD resulted in a prescription for a central nervous system stimulant drug, including methylphenidate, dexmethylphenidate, and amphetamine/dextroamphetamine. The study was intended to assess the amount of child health care directed to ADHD, and does not speak to whether the disorder is being overtreated or undertreated, Ashman said.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »